New horizons in kidney transplantation
Immune Tolerance
Kidney transplant recipients normally take anti-rejection drugs to help protect the transplanted kidney. The study will use a new approach to see if patients can reduce or stop anti-rejection drugs.
What is Immune Tolerance?
Immune tolerance means a transplant patient can keep their kidney without taking anti-rejection drugs.
These drugs prevent rejection but can have serious side effects such as infections, heart problems, tremors, cancer and reduced function in the transplanted kidney.
The Panorama Study is evaluating an experimental treatment approach that could eliminate the need for anti-rejection drugs for living donor kidney transplant recipients. For more information click below.
About PanoramaStudy now enrolling patients
If you are a kidney failure patient who can receive a kidney transplant from a living donor, you may be eligible to participate in the Panorama Study.
This website provides you with an overview of the study and important information for transplant recipients and their living donors.
For additional information, please click below to reach the eligibility page and answer three short questions.
Study Eligibility